328 related articles for article (PubMed ID: 27790711)
1. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
[TBL] [Abstract][Full Text] [Related]
2. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
Trobridge P; Knoblaugh S; Washington MK; Munoz NM; Tsuchiya KD; Rojas A; Song X; Ulrich CM; Sasazuki T; Shirasawa S; Grady WM
Gastroenterology; 2009 May; 136(5):1680-8.e7. PubMed ID: 19208363
[TBL] [Abstract][Full Text] [Related]
5. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.
Starr TK; Scott PM; Marsh BM; Zhao L; Than BL; O'Sullivan MG; Sarver AL; Dupuy AJ; Largaespada DA; Cormier RT
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5765-70. PubMed ID: 21436051
[TBL] [Abstract][Full Text] [Related]
6. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
10. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
12. Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression.
Takeda H; Wei Z; Koso H; Rust AG; Yew CC; Mann MB; Ward JM; Adams DJ; Copeland NG; Jenkins NA
Nat Genet; 2015 Feb; 47(2):142-50. PubMed ID: 25559195
[TBL] [Abstract][Full Text] [Related]
13. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
[TBL] [Abstract][Full Text] [Related]
14. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
[TBL] [Abstract][Full Text] [Related]
15. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
[TBL] [Abstract][Full Text] [Related]
16. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor.
Borczuk AC; Sole M; Lu P; Chen J; Wilgus ML; Friedman RA; Albelda SM; Powell CA
Cancer Res; 2011 Nov; 71(21):6665-75. PubMed ID: 21911454
[TBL] [Abstract][Full Text] [Related]
17. The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.
Rojas A; Meherem S; Kim YH; Washington MK; Willis JE; Markowitz SD; Grady WM
Int J Cancer; 2008 Jul; 123(1):14-21. PubMed ID: 18425817
[TBL] [Abstract][Full Text] [Related]
18. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
19. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.
Starr TK; Allaei R; Silverstein KA; Staggs RA; Sarver AL; Bergemann TL; Gupta M; O'Sullivan MG; Matise I; Dupuy AJ; Collier LS; Powers S; Oberg AL; Asmann YW; Thibodeau SN; Tessarollo L; Copeland NG; Jenkins NA; Cormier RT; Largaespada DA
Science; 2009 Mar; 323(5922):1747-50. PubMed ID: 19251594
[TBL] [Abstract][Full Text] [Related]
20. Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR.
Janik CL; Starr TK
J Vis Exp; 2013 Feb; (72):e50156. PubMed ID: 23407503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
